Inflammation, immune suppression, and tumor progression

Gespeichert in:

Autor*in:	Ostrand-Rosenberg, Suzanne [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2013

Schlagwörter:	Tumor Microenvironment Immune Suppression Suppressive Activity Cancer Immunotherapy Suppressive Function

Anmerkung:	© Ostrand-Rosenberg; licensee BioMed Central Ltd. 2013

Übergeordnetes Werk:	Enthalten in: BMC proceedings - London : BioMed Central, 2007, 7(2013), Suppl 2 vom: 04. Apr.
Übergeordnetes Werk:	volume:7 ; year:2013 ; number:Suppl 2 ; day:04 ; month:04

Links:	Volltext

DOI / URN:	10.1186/1753-6561-7-S2-K20

Katalog-ID:	SPR028451686

Internformat


LEADER	01000caa a22002652 4500
001	SPR028451686
003	DE-627
005	20230519174154.0
007	cr uuu---uuuuu
008	201007s2013 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1186/1753-6561-7-S2-K20 \|2 doi
035			\|a (DE-627)SPR028451686
035			\|a (SPR)1753-6561-7-S2-K20-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
100	1		\|a Ostrand-Rosenberg, Suzanne \|e verfasserin \|4 aut
245	1	0	\|a Inflammation, immune suppression, and tumor progression
264		1	\|c 2013
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Ostrand-Rosenberg; licensee BioMed Central Ltd. 2013
650		4	\|a Tumor Microenvironment \|7 (dpeaa)DE-He213
650		4	\|a Immune Suppression \|7 (dpeaa)DE-He213
650		4	\|a Suppressive Activity \|7 (dpeaa)DE-He213
650		4	\|a Cancer Immunotherapy \|7 (dpeaa)DE-He213
650		4	\|a Suppressive Function \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t BMC proceedings \|d London : BioMed Central, 2007 \|g 7(2013), Suppl 2 vom: 04. Apr. \|w (DE-627)559080840 \|w (DE-600)2411867-9 \|x 1753-6561 \|7 nnns
773	1	8	\|g volume:7 \|g year:2013 \|g number:Suppl 2 \|g day:04 \|g month:04
856	4	0	\|u https://dx.doi.org/10.1186/1753-6561-7-S2-K20 \|z kostenfrei \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_31
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_2027
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 7 \|j 2013 \|e Suppl 2 \|b 04 \|c 04

Indexfelder

author_variant	s o r sor
matchkey_str	article:17536561:2013----::nlmainmueupesoaduo
hierarchy_sort_str	2013
publishDate	2013
allfields	10.1186/1753-6561-7-S2-K20 doi (DE-627)SPR028451686 (SPR)1753-6561-7-S2-K20-e DE-627 ger DE-627 rakwb eng Ostrand-Rosenberg, Suzanne verfasserin aut Inflammation, immune suppression, and tumor progression 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Ostrand-Rosenberg; licensee BioMed Central Ltd. 2013 Tumor Microenvironment (dpeaa)DE-He213 Immune Suppression (dpeaa)DE-He213 Suppressive Activity (dpeaa)DE-He213 Cancer Immunotherapy (dpeaa)DE-He213 Suppressive Function (dpeaa)DE-He213 Enthalten in BMC proceedings London : BioMed Central, 2007 7(2013), Suppl 2 vom: 04. Apr. (DE-627)559080840 (DE-600)2411867-9 1753-6561 nnns volume:7 year:2013 number:Suppl 2 day:04 month:04 https://dx.doi.org/10.1186/1753-6561-7-S2-K20 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2027 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 7 2013 Suppl 2 04 04
spelling	10.1186/1753-6561-7-S2-K20 doi (DE-627)SPR028451686 (SPR)1753-6561-7-S2-K20-e DE-627 ger DE-627 rakwb eng Ostrand-Rosenberg, Suzanne verfasserin aut Inflammation, immune suppression, and tumor progression 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Ostrand-Rosenberg; licensee BioMed Central Ltd. 2013 Tumor Microenvironment (dpeaa)DE-He213 Immune Suppression (dpeaa)DE-He213 Suppressive Activity (dpeaa)DE-He213 Cancer Immunotherapy (dpeaa)DE-He213 Suppressive Function (dpeaa)DE-He213 Enthalten in BMC proceedings London : BioMed Central, 2007 7(2013), Suppl 2 vom: 04. Apr. (DE-627)559080840 (DE-600)2411867-9 1753-6561 nnns volume:7 year:2013 number:Suppl 2 day:04 month:04 https://dx.doi.org/10.1186/1753-6561-7-S2-K20 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2027 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 7 2013 Suppl 2 04 04
allfields_unstemmed	10.1186/1753-6561-7-S2-K20 doi (DE-627)SPR028451686 (SPR)1753-6561-7-S2-K20-e DE-627 ger DE-627 rakwb eng Ostrand-Rosenberg, Suzanne verfasserin aut Inflammation, immune suppression, and tumor progression 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Ostrand-Rosenberg; licensee BioMed Central Ltd. 2013 Tumor Microenvironment (dpeaa)DE-He213 Immune Suppression (dpeaa)DE-He213 Suppressive Activity (dpeaa)DE-He213 Cancer Immunotherapy (dpeaa)DE-He213 Suppressive Function (dpeaa)DE-He213 Enthalten in BMC proceedings London : BioMed Central, 2007 7(2013), Suppl 2 vom: 04. Apr. (DE-627)559080840 (DE-600)2411867-9 1753-6561 nnns volume:7 year:2013 number:Suppl 2 day:04 month:04 https://dx.doi.org/10.1186/1753-6561-7-S2-K20 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2027 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 7 2013 Suppl 2 04 04
allfieldsGer	10.1186/1753-6561-7-S2-K20 doi (DE-627)SPR028451686 (SPR)1753-6561-7-S2-K20-e DE-627 ger DE-627 rakwb eng Ostrand-Rosenberg, Suzanne verfasserin aut Inflammation, immune suppression, and tumor progression 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Ostrand-Rosenberg; licensee BioMed Central Ltd. 2013 Tumor Microenvironment (dpeaa)DE-He213 Immune Suppression (dpeaa)DE-He213 Suppressive Activity (dpeaa)DE-He213 Cancer Immunotherapy (dpeaa)DE-He213 Suppressive Function (dpeaa)DE-He213 Enthalten in BMC proceedings London : BioMed Central, 2007 7(2013), Suppl 2 vom: 04. Apr. (DE-627)559080840 (DE-600)2411867-9 1753-6561 nnns volume:7 year:2013 number:Suppl 2 day:04 month:04 https://dx.doi.org/10.1186/1753-6561-7-S2-K20 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2027 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 7 2013 Suppl 2 04 04
allfieldsSound	10.1186/1753-6561-7-S2-K20 doi (DE-627)SPR028451686 (SPR)1753-6561-7-S2-K20-e DE-627 ger DE-627 rakwb eng Ostrand-Rosenberg, Suzanne verfasserin aut Inflammation, immune suppression, and tumor progression 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Ostrand-Rosenberg; licensee BioMed Central Ltd. 2013 Tumor Microenvironment (dpeaa)DE-He213 Immune Suppression (dpeaa)DE-He213 Suppressive Activity (dpeaa)DE-He213 Cancer Immunotherapy (dpeaa)DE-He213 Suppressive Function (dpeaa)DE-He213 Enthalten in BMC proceedings London : BioMed Central, 2007 7(2013), Suppl 2 vom: 04. Apr. (DE-627)559080840 (DE-600)2411867-9 1753-6561 nnns volume:7 year:2013 number:Suppl 2 day:04 month:04 https://dx.doi.org/10.1186/1753-6561-7-S2-K20 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2027 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 7 2013 Suppl 2 04 04
language	English
source	Enthalten in BMC proceedings 7(2013), Suppl 2 vom: 04. Apr. volume:7 year:2013 number:Suppl 2 day:04 month:04
sourceStr	Enthalten in BMC proceedings 7(2013), Suppl 2 vom: 04. Apr. volume:7 year:2013 number:Suppl 2 day:04 month:04
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Tumor Microenvironment Immune Suppression Suppressive Activity Cancer Immunotherapy Suppressive Function
isfreeaccess_bool	true
container_title	BMC proceedings
authorswithroles_txt_mv	Ostrand-Rosenberg, Suzanne @@aut@@
publishDateDaySort_date	2013-04-04T00:00:00Z
hierarchy_top_id	559080840
id	SPR028451686
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR028451686</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519174154.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2013 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/1753-6561-7-S2-K20</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR028451686</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)1753-6561-7-S2-K20-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ostrand-Rosenberg, Suzanne</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Inflammation, immune suppression, and tumor progression</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Ostrand-Rosenberg; licensee BioMed Central Ltd. 2013</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tumor Microenvironment</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immune Suppression</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Suppressive Activity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer Immunotherapy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Suppressive Function</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">BMC proceedings</subfield><subfield code="d">London : BioMed Central, 2007</subfield><subfield code="g">7(2013), Suppl 2 vom: 04. Apr.</subfield><subfield code="w">(DE-627)559080840</subfield><subfield code="w">(DE-600)2411867-9</subfield><subfield code="x">1753-6561</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:7</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:Suppl 2</subfield><subfield code="g">day:04</subfield><subfield code="g">month:04</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1186/1753-6561-7-S2-K20</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2027</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">7</subfield><subfield code="j">2013</subfield><subfield code="e">Suppl 2</subfield><subfield code="b">04</subfield><subfield code="c">04</subfield></datafield></record></collection>
author	Ostrand-Rosenberg, Suzanne
spellingShingle	Ostrand-Rosenberg, Suzanne misc Tumor Microenvironment misc Immune Suppression misc Suppressive Activity misc Cancer Immunotherapy misc Suppressive Function Inflammation, immune suppression, and tumor progression
authorStr	Ostrand-Rosenberg, Suzanne
ppnlink_with_tag_str_mv	@@773@@(DE-627)559080840
format	electronic Article
delete_txt_mv	keep
author_role	aut
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	1753-6561
topic_title	Inflammation, immune suppression, and tumor progression Tumor Microenvironment (dpeaa)DE-He213 Immune Suppression (dpeaa)DE-He213 Suppressive Activity (dpeaa)DE-He213 Cancer Immunotherapy (dpeaa)DE-He213 Suppressive Function (dpeaa)DE-He213
topic	misc Tumor Microenvironment misc Immune Suppression misc Suppressive Activity misc Cancer Immunotherapy misc Suppressive Function
topic_unstemmed	misc Tumor Microenvironment misc Immune Suppression misc Suppressive Activity misc Cancer Immunotherapy misc Suppressive Function
topic_browse	misc Tumor Microenvironment misc Immune Suppression misc Suppressive Activity misc Cancer Immunotherapy misc Suppressive Function
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	BMC proceedings
hierarchy_parent_id	559080840
hierarchy_top_title	BMC proceedings
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)559080840 (DE-600)2411867-9
title	Inflammation, immune suppression, and tumor progression
ctrlnum	(DE-627)SPR028451686 (SPR)1753-6561-7-S2-K20-e
title_full	Inflammation, immune suppression, and tumor progression
author_sort	Ostrand-Rosenberg, Suzanne
journal	BMC proceedings
journalStr	BMC proceedings
lang_code	eng
isOA_bool	true
recordtype	marc
publishDateSort	2013
contenttype_str_mv	txt
author_browse	Ostrand-Rosenberg, Suzanne
container_volume	7
format_se	Elektronische Aufsätze
author-letter	Ostrand-Rosenberg, Suzanne
doi_str_mv	10.1186/1753-6561-7-S2-K20
title_sort	inflammation, immune suppression, and tumor progression
title_auth	Inflammation, immune suppression, and tumor progression
abstract	© Ostrand-Rosenberg; licensee BioMed Central Ltd. 2013
abstractGer	© Ostrand-Rosenberg; licensee BioMed Central Ltd. 2013
abstract_unstemmed	© Ostrand-Rosenberg; licensee BioMed Central Ltd. 2013
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2027 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
container_issue	Suppl 2
title_short	Inflammation, immune suppression, and tumor progression
url	https://dx.doi.org/10.1186/1753-6561-7-S2-K20
remote_bool	true
ppnlink	559080840
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.1186/1753-6561-7-S2-K20
up_date	2024-07-03T19:31:59.142Z
_version_	1803587545091538944
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR028451686</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519174154.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2013 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/1753-6561-7-S2-K20</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR028451686</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)1753-6561-7-S2-K20-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ostrand-Rosenberg, Suzanne</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Inflammation, immune suppression, and tumor progression</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Ostrand-Rosenberg; licensee BioMed Central Ltd. 2013</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tumor Microenvironment</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immune Suppression</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Suppressive Activity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer Immunotherapy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Suppressive Function</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">BMC proceedings</subfield><subfield code="d">London : BioMed Central, 2007</subfield><subfield code="g">7(2013), Suppl 2 vom: 04. Apr.</subfield><subfield code="w">(DE-627)559080840</subfield><subfield code="w">(DE-600)2411867-9</subfield><subfield code="x">1753-6561</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:7</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:Suppl 2</subfield><subfield code="g">day:04</subfield><subfield code="g">month:04</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1186/1753-6561-7-S2-K20</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2027</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">7</subfield><subfield code="j">2013</subfield><subfield code="e">Suppl 2</subfield><subfield code="b">04</subfield><subfield code="c">04</subfield></datafield></record></collection>
score	7.4010878

Nicht das Richtige dabei?

Schreiben Sie uns!

Inflammation, immune suppression, and tumor progression

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?